Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

FDA approves first factor XIa inhibitor for secondary stroke prevention

Just now November 18, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

The FDA approved Sunharbo (asundexian), a new factor XIa inhibitor medication for stroke prevention in adults with recent mild-to-moderate ischemic strokes or high-risk TIAs. This is a pharmaceutical advancement by U.S. regulatory authorities with no direct connection to Iran.

The U.S. Food and Drug Administration has approved Sunharbo (asundexian) 50 mg tablets, in combination with antiplatelet therapy, to reduce the risk for stroke in adults following a recent mild-to-moderate noncardioembolic ischemic stroke or a high-risk transient ischemic attack (TIA).

🏷️ Entities Mentioned

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →